Skip to main content
. 2022 Oct 1:10.1002/jmv.28163. Online ahead of print. doi: 10.1002/jmv.28163

Figure 2.

Figure 2

Comparative analysis of anti‐Wuhan, Delta, and Omicron variant receptor binding domain (RBD) antibody IgG levels in Omicron variant‐infected patients (OIPs) with different clinical parameters. (A–C) The anti‐Wuhan (A), Delta (B), and Omicron variant (C) RBD antibody IgG titers in unvaccinated OIPs and OIPs pre‐vaccination with an inactivated vaccine (pre‐vaccinated OIPs). (D–F) The anti‐Wuhan (D), Delta (E), and Omicron variant (F) RBD antibody IgG titers in pre‐vaccinated OIPs during 0–5, 6–10, and 11–22 days after infection. (G–I) The anti‐Wuhan (G), Delta (H), and Omicron variants (I) RBD antibody IgG titers in pre‐vaccinated OIPs who were asymptomatic and those with mild and moderate infection during 0–5, 6–10, and 11–22 days after infection. AS, asymptomatic; DPI, days postinfection, GMT, geometric mean titer. Dotted line represents the detection of limits.